SCHEMBL6709991

SCHEMBL6709991

O=C(Nc1cccc2cc(C(=O)Nc3ccc(Cl)cc3-c3noc(=O)[nH]3)[nH]c12)c1ccc(Cl)nc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 2/20 0.44
GRIK1 P39086 1/20 0.42
MDM4 O15151 1/20 0.40
TP53 P04637 1/20 0.40
MDM2 Q00987 1/20 0.40
F10 P00742 1/20 0.40
PLCG2 P16885 1/20 0.40
STK33 Q9BYT3 1/20 0.39
KCNQ3 O43525 2/20 0.39
KCNQ2 O43526 2/20 0.39
KCNE1 P15382 2/20 0.39
KCNQ1 P51787 2/20 0.39
KMT2A Q03164 2/20 0.38
MAPT P10636 2/20 0.38
MEN1 O00255 1/20 0.38
LMNA P02545 1/20 0.38
HTT P42858 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
GAA P10253 2/20 0.38
L3MBTL1 Q9Y468 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6713714 0.92 KDR (0.43) KDRGRIK1MDM4TP53MDM2
SCHEMBL6710141 0.91 GRIK1 (0.44) GRIK1PLCG2STK33NPSR1KDM4E
SCHEMBL6714034 0.90 KMT2A (0.47) KDRGRIK1MDM4TP53MDM2
SCHEMBL6709929 0.89 GRIK1 (0.49) KDRGRIK1PLCG2STK33MAPT
SCHEMBL6713155 0.88 SERPINE1 (0.48) GRIK1F10PLCG2STK33KMT2A
SCHEMBL6709173 0.87 GRIK1 (0.44) GRIK1TP53PLCG2STK33KMT2A
SCHEMBL6713656 0.87 GRIK1 (0.42) GRIK1TP53PLCG2STK33KCNQ3
SCHEMBL6708655 0.86 NHERF1 (0.46) GRIK1PLCG2STK33KMT2AMEN1
SCHEMBL6920022 0.86 KDR (0.40) KDRGRIK1MDM4TP53MDM2
SCHEMBL6707691 0.85 GRIK1 (0.41) KDRGRIK1TP53F10PLCG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 KDR 3770/4885GRIK1 3885/4885MDM4 2984/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.